No Data
No Data
Express News | Singular Genomics Regains Nasdaq Compliance
Express News | Singular Genomics Regains Compliance With Nasdaq Minimum Bid Price Requirement
Goldman Sachs Adjusts Price Target on Singular Genomics Systems to $6.50 From $22.50, Maintains Neutral Rating
Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $6.5
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
No Data